Work

A Phase 2 Multicenter Study of Continuous Dose Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.1623.1623

Authors: Todd A. Fehniger, Sarah Larson, Kathryn Trinkaus, Marilyn J. Siegel, David D. Hurd, Kristie A. Blum, Andre Goy, Timothy S. Fenske, Amanda Cashen, Nina D. Wagner-Johnston, Kenneth R. Carson, Nancy L. Bartlett

Institutions: Washington University in St. Louis, Wake Forest University Health Sciences, Wake Forest University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Hackensack University Medical Center, Medical College of Wisconsin

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2537548903

FWCI: 0.417

Cites:

Cited by: 11

Related to: 10